Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Colloid Interface Sci ; 349(1): 314-20, 2010 Sep 01.
Article in English | MEDLINE | ID: mdl-20621813

ABSTRACT

We prepared a novel Zr-modified MgFe-LDH(CO(3)) composite by adding a mixed solution of MgCl(2), FeCl(3), and ZrOCl(2) and another mixed solution of 1mol/dm(3) NaOH and 1mol/dm(3) Na(2)CO(3) to distilled water at a constant pH of 10. The composite exhibited only a poorly crystalline structure, resembling that of layered double hydroxides (LDH) from X-ray diffraction. The phosphate uptake is dependent on pH, decreasing with an increase in pH. This composite shows a much greater uptake of phosphate ions in P-enriched seawater (0.33mg-P/dm(3)) than amorphous zirconium oxide and MgFe-LDH(CO(3)). The uptake isotherm was fitted with a Freundlich relation. These phosphate-uptake behaviors closely resemble those of the relevant Zr-MgAl-LDH, which is estimated to be a composite of MgAl-LDH with amorphous zirconium hydroxide on the surface from X-ray absorption spectroscopy. Therefore, a similar structure of Zr-modified MgFe-LDH(CO(3)) composite probably causes the marked increase in phosphate uptake from P-enriched seawater.


Subject(s)
Hydroxides/chemistry , Phosphates/isolation & purification , Seawater/chemistry , Water Pollutants, Chemical/isolation & purification , Zirconium/chemistry , Adsorption , X-Ray Diffraction
2.
J Colloid Interface Sci ; 313(1): 53-63, 2007 Sep 01.
Article in English | MEDLINE | ID: mdl-17509605

ABSTRACT

We synthesized Zr(4+) incorporated MgAl-layered double hydroxides, Mg(AlZr)-LDH(A) (where A denotes a counteranion in the interlayer space and is expressed as CO(3) for carbonate and Cl for chloride ions), with different molar ratios of Mg/(Al+Zr). Then we characterized their uptake behavior toward phosphate ions. CO(3)-type tertiary LDH materials synthesized at room temperature show low crystallinity, whereas the highly crystalline Cl-type tertiary LDH, [Mg(0.68)Al(0.17)Zr(0.14)(OH)(2)][Cl(0.26)(CO(3))(0.04)1.24H(2)O], was synthesized for the first time using a hydrothermal treatment at 120 degrees C. The distribution coefficients (K(d)) of oxo-anions were measured with a mixed solution containing trace amounts of the anions. The selectivity sequences were Cl(-), NO(-)(3)

3.
J Colloid Interface Sci ; 298(2): 602-8, 2006 Jun 15.
Article in English | MEDLINE | ID: mdl-16455102

ABSTRACT

Low crystalline iron hydroxides such as goethite (alpha-FeOOH) and akaganeite (beta-FeOOH) were synthesized, and the selective adsorption of phosphate ions from phosphate-enriched seawater was examined. The results of the distribution coefficients (K(d)) of oxoanions in mixed anion solutions at pH 8 follow the selectivity order Cl-, NO3-, SO4(2-) << CO3(2-), HPO4(2-) for goethite, and Cl-, CO3(2-) < NO3- < SO4(2) << HPO4(2-) for akaganeite. In seawater, both adsorbents show high selectivity for phosphate ions despite the presence of large amounts of major cations and anions in seawater. The adsorption isotherms fitted better with the Freundlich equation and the maximum uptake of phosphate from phosphate-enriched seawater was 10 mg P/g at an equilibrium phosphate concentration of 0.3 mg P/L on both adsorbents. The phosphate adsorption/desorption cycles show that akaganeite is an excellent adsorbent even after 10 cycles and its chemical stability is good.

4.
J Colloid Interface Sci ; 297(2): 426-33, 2006 May 15.
Article in English | MEDLINE | ID: mdl-16337645

ABSTRACT

Phosphate adsorption from single electrolyte (NaH2PO4), phosphate-enriched seawater, and model wastewater was studied using amorphous zirconium hydroxide, ZrO(OH)2(Na2O)0.05 1.5H2O, as an adsorbent. Batch experiments were carried out to investigate the adsorption of phosphate. The effect of pH on phosphate adsorption from seawater showed that the uptake of phosphate increased with an increase in pH up to 6, and then decreased sharply with a further increase in pH of the solution. The equilibrium data of phosphate adsorption were followed with a Freundlich isotherm. The uptake of phosphate at the adsorbent/solution ratio 0.05 g/2 L was 10 and 17 mg-P/g for the phosphate-enriched seawater and the model wastewater, respectively. A much higher adsorptivity toward phosphate ions in seawater was observed on ZrO(OH)2(Na2O)0.05 1.5H(2)O than on other representative adsorbents based on layered double hydroxides of Mg(II)-Al(III), Mg(II)-Fe(III), and Ni(II)-Fe(III). The effective desorption of phosphate ions on ZrO(OH)2(Na2O)0.05 1.5H2O could be achieved using a 0.1 M NaOH solution. The usefulness of experimental data for practical applications in removing phosphate in seawater and wastewater is discussed.


Subject(s)
Hydroxides/chemistry , Phosphates/isolation & purification , Seawater/chemistry , Water Pollutants, Chemical/isolation & purification , Water Purification/methods , Zirconium/chemistry , Adsorption , Models, Chemical , Waste Disposal, Fluid
5.
J Colloid Interface Sci ; 290(1): 45-51, 2005 Oct 01.
Article in English | MEDLINE | ID: mdl-15925378

ABSTRACT

Adsorptive properties of MgMn-3-300 (MgMn-type layered double hydroxide with Mg/Mn mole ratio of 3, calcined at 300 degrees C) for phosphate were investigated in phosphate-enriched seawater with a concentration of 0.30 mg-P/dm3. It showed the highest phosphate uptake from the seawater among the inorganic adsorbents studied (hydrotalcite, calcined hydrotalcite, activated magnesia, hydrous aluminum oxide, manganese oxide (delta-MnO2)). The phosphate uptake by MgMn-3-300 reached 7.3 mg-P/g at an adsorbent/solution ratio of 0.05 g/2 dm3. The analyses of the uptakes of other constituents (Na+, K+, Ca(+, Cl-, and SO(2-)4) of seawater showed that the adsorbent had a markedly high selectivity for the adsorption of phosphate ions. Effects of initial phosphate concentration, temperature, pH, and salinity on phosphate uptake were investigated in detail by a batch method. The phosphate uptake increased slightly with an increase in the adsorption temperature. The adsorption isotherm followed Freundlich's equation with constants of logK(F)=1.25 and 1/n=0.65, indicating that it could effectively remove phosphate even from a solution of markedly low phosphate concentration as well as with large numbers of coexisting ions. The pH dependence showed a maximum phosphate uptake around pH 8.5. The pH dependence curve suggested that selective phosphate adsorption progresses mainly by the ion exchange of HPO(2-)4. The study on the effect of salinity suggested the presence of two kinds of adsorption sites in the adsorbent: one nonspecific site with weak interaction and one specific site with strong interaction. The effective desorption of phosphate could be achieved using a mixed solution of 5 M NaCl + 0.1 M NaOH (1 M = 1 mol/dm3), with negligible dissolution of adsorbent. The adsorbent had high chemical stability against the adsorption/desorption cycle; it kept a good phosphate uptake even after the repetition of the seventh cycle.


Subject(s)
Hydroxides/chemistry , Magnesium/chemistry , Manganese/chemistry , Phosphates/chemistry , Seawater/chemistry , Adsorption , Hot Temperature , Hydrogen-Ion Concentration , Sodium Chloride/chemistry , Surface Properties
6.
Br J Pharmacol ; 142(7): 1137-46, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15249421

ABSTRACT

Previous studies showed that nicotine induces adrenergic nerve-dependent vasodilation that is mediated by endogenous calcitonin gene-related peptide (CGRP) released from CGRP-containing (CGRPergic) nerves. The mechanisms underlying the nicotine-induced vasodilation were further studied. Rat mesenteric vascular beds without endothelium were contracted by perfusion with Krebs solution containing methoxamine, and the perfusion pressure was measured with a pressure transducer. Perfusion of nicotine (1-100 microm) for 1 min caused concentration-dependent vasodilation. Capsazepine (vanilloid receptor-1 antagonist; 1-10 microm) and ruthenium red (inhibitor of vanilloid response; 1-30 microm) concentration-dependently inhibited the nicotine-induced vasodilation without affecting the vasodilator response to exogenous CGRP. Nicotine-induced vasodilation was not inhibited by treatment with 3,4-dihydroxyphenylalanine (DOPA) receptor antagonist (l-DOPA cyclohexyl ester; 0.001-10 microm), dopamine D1 receptor-selective antagonist (SCH23390; 1-10 microm), dopamine D2 receptor antagonist (haloperidol; 0.1-0.5 microm), ATP P2x receptor-desensitizing agonist (alpha,beta-methylene ATP; 1-10 microm), adenosine A2 receptor antagonist (8(p-sulfophenyl)theophylline; 10-50 microm) or neuropeptide Y (NPY)-Y1 receptor antagonist (BIBP3226; 0.1-0.5 microm). Immunohistochemical staining of the mesenteric artery showed dense innervation of CGRP- and vanilloid receptor-1-positive nerves, with both immunostainings appearing in the same neuron. The mesenteric artery was also densely innervated by NPY-positive nerves. Double immunostainings showed that both NPY and CGRP immunoreactivities appeared in the same neuron of the artery. These results suggest that nicotine acts on presynaptic nicotinic receptors to release adrenergic neurotransmitter(s) or related substance(s), which then stimulate vanilloid receptor-1 on CGRPergic nerves, resulting in CGRP release and vasodilation.


Subject(s)
Adrenergic Fibers/drug effects , Calcitonin Gene-Related Peptide/physiology , Mesenteric Arteries/drug effects , Mesenteric Arteries/innervation , Nicotine/pharmacology , Receptors, Drug/physiology , Vasodilation , Vasodilator Agents/pharmacology , Adrenergic Fibers/physiology , Animals , Calcitonin Gene-Related Peptide Receptor Antagonists , Dopamine Antagonists/pharmacology , Dose-Response Relationship, Drug , Electric Stimulation , Male , Mesenteric Arteries/physiology , Microscopy, Confocal , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/innervation , Muscle, Smooth, Vascular/physiology , Nicotine/administration & dosage , Purinergic P1 Receptor Antagonists , Purinergic P2 Receptor Antagonists , Rats , Rats, Wistar , Receptors, Calcitonin Gene-Related Peptide/metabolism , Receptors, Drug/antagonists & inhibitors , Receptors, Neuropeptide Y/antagonists & inhibitors , Receptors, Neuropeptide Y/metabolism , Receptors, Purinergic P1/metabolism , Receptors, Purinergic P2/metabolism , Ruthenium Red/administration & dosage , Ruthenium Red/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...